- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Lisa Kroon, PharmD
Thomas A. Oliver Professor of Clinical Pharmacy
Assistant Chief Pharmacy Officer, Clinical Innovation, Education and Research, UCSF Health
Phone: +1 415 476-1687
Fax: +1 415 476-6632
521 Parnassus Avenue, Rm 3615
UCSF Box 0622
San Francisco, CA 94117
United States Links
Affiliations
Education programs
UCSF centers, institutes, and research programs
Codirector, UCSF Fontana Tobacco Treatment Center12
Executive Director, Medication Outcomes Center13
Pharmacist, Diabetes Clinic14
School committees and service
UCSF Health Pharmacy Residency Diversity Council, 2022-present, University of California San Francisco
What I do
At UCSF Health, I am the Assistant Chief Pharmacy Officer (ACPO) of Clinical Innovation, Education and Research and oversee ambulatory pharmacy practice. As an APCO, I am a member of UCSF Health’s Pharmacy Enterprise Executive Leadership Team that sets strategic direction, priorities and goals for the enterprise. I maintain my faculty position as a Professor of Clinical Pharmacy in the School of Pharmacy where I continue to teach in the Doctor of Pharmacy curriculum and conduct clinical research. My research and practice efforts focus on evaluating the impact of pharmacist provider status and expanded scope of practice, diabetes therapeutics, tobacco cessation, and innovative practice models in the ambulatory and community pharmacy setting.
Departmental research area
My research expertise
testing innovative pharmacist care programs in the ambulatory and community pharmacy setting, evaluating the impact of pharmacists’ expanded scope of practice and provider status, diabetes therapeutics, pharmacy-based smoking cessation services and interventions
Clinical expertise
adult diabetes, tobacco and smoking cessation
Professional background
Degrees
PharmD, University of Michigan, 1994
Postgraduate training
PGY2, Hospital Pharmacy Administration Residency, University of California, San Francisco, 1996
PGY1, Pharmacy Practice Residency, University of California, San Francisco, 1995
Licensure and certifications
Diabetes Care and Education Specialist, Certified, 1999
Licentiate in Pharmacy, California State Board of Pharmacy, 1995
Training and professional development
Diversity, Equity, and Inclusion Champion Training, University of California San Francisco, 2021
Biography
Dr. Lisa Kroon is a Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California in San Francisco. She holds an executive pharmacy leadership role at UCSF Health since 2020, where she was appointed the Assistant Chief Pharmacy Officer for Clinical Innovation, Education, and Research for the Pharmacy Enterprise, where she oversees ambulatory pharmacy practice. Dr. Kroon received her Doctor of Pharmacy at the University of Michigan and then completed two years of residency at UCSF in pharmacy practice and hospital pharmacy administration. She has been a member of the UCSF faculty since 1996. She practices in the UCSF Medical Center’s Adult Diabetes Clinic and Diabetes Teaching Center, where she cares for people with diabetes and chronic illnesses. She co-directs the Fontana Tobacco Treatment Center (www.ucsfhealth.org/tobaccotreatment16). Her current research interests include evaluating the impact of pharmacist provider status and expanded scope of practice, diabetes therapeutics, tobacco cessation, and innovative practice models in the community pharmacy setting.
Research keywords
- Patient Education as Topic
- drug interactions
- Cultural Characteristics
- Hypoglycemic Agents
- smoking cessation
- Type 2 Diabetes Mellitus
- Glucagon-Like Peptide 1
- Drug Prescriptions
- drug delivery systems
- Community Pharmacy Services
- Occult Blood
- Immunization Programs
- Injections, Subcutaneous
- tobacco cessation
- pharmacies
1. | Pharmacist of the Year, California Society of Health-System Pharmacists, 2019 |
2. | Fellow of the Academy of Pharmacy Practice and Management, American Pharmacists Association, 2016 |
3. | 150th Anniversary Alumni Excellence Award, UCSF, 2015 |
4. | Apple for Teachers Award for Excellence in Teaching, UCSF School of Pharmacy, 2013-2022 |
5. | Advisor of the Year, Academy of Students of Pharmacy, UCSF Chapter, 2012 |
6. | Outstanding Teacher of the Year, San Francisco Program, Long Award for Excellence in Teaching, UCSF School of Pharmacy, 2012 |
7. | Best Practices Award, Academy of Pharmacy Educators, California Pharmacists Association, 2011 |
8. | Apple for Teachers Award for Excellence in Teaching, UCSF School of Pharmacy, 2009-2010 |
9. | Preceptor of the Year, Academy of Students of Pharmacy, UCSF Chapter, 2003-2004 |
10. | Practioner Fellow, California Society of Health-System Pharmacists, 2002 |
11. | Elected into Phi Lambda Sigma, an honorary pharmacy leadership society, Phi Lambda Sigma, 1998 |
12. | Member, Rho Chi Pharmacy Honor Society, 1992 |
Publications
Kui K, Hailozian C, Thai M, Chakravarty D, Apollonio DE, Kroon L, Vijayaraghavan M. Tobacco cessation, mental health, and substance use in a community pharmacist-linked cessation program for people experiencing homelessness. Drug Alcohol Depend. 2024 Dec 18; 267:112527. |
Tamraz B, Shin J, Khanna R, Van Ziffle J, Knowles S, Stregowski S, Wan E, Kamath R, Collins C, Phunsur C, Tsai B, Kong P, Calanoc C, Pollard A, Sawhney R, Pleiman J, Devine WP, Croci R, Sashikanth A, Kroon L, Cucina R, Rajkovic A. Clinical implementation of preemptive pharmacogenomics testing for personalized medicine at an academic medical center. J Am Med Inform Assoc. 2024 Dec 12. |
De Los Reyes G, Ng A, Valencia Chavez J, Apollonio DE, Kroon L, Lee P, Vijayaraghavan M. Evaluation of a Pharmacist-Linked Smoking Cessation Intervention for Adults Experiencing Homelessness. Subst Use Misuse. 2023; 58(12):1519-1527. |
Hartman-Filson M, Chen J, Lee P, Phan M, Apollonio DE, Kroon L, Donald F, Vijayaraghavan M. A community-based tobacco cessation program for individuals experiencing homelessness. Addict Behav. 2022 06; 129:107282. |
Kennedy DR, Clapp P, DeLuca JL, Filtz TM, Kroon L, Lamberts JT, Oliphant CM, Prescott WA, Ray SD. Enhancing Pharmacy Faculty Well-Being and Productivity While Reducing Burnout. Am J Pharm Educ. 2022 06; 86(5):8764. |
Corelli RL, Merchant KR, Hilts KE, Kroon LA, Vatanka P, Hille BT, Hudmon KS. Community pharmacy technicians' engagement in the delivery of brief tobacco cessation interventions: Results of a randomized trial. Res Social Adm Pharm. 2022 07; 18(7):3158-3163. |
Rafie S, Kroon L, Schweitzer P. Access To Birth Control At Community Pharmacies. Health Aff (Millwood). 2021 01; 40(1):178. |
Christine Lin, Rebecca Strauss, Jenny Hong, Jeffrey G. Hamper, Emma Sew Hoy, Ann A. Lazar, Lisa Kroon. Impact of a pharmacist-administered long-acting injectable antipsychotic service in a supermarket-based community pharmacy on medication adherence. Journal of the American College of Clinical Pharmacy. 2019 Aug 1; 2(4):343-348. |
Lu S, Rafie S, Hamper J, Strauss R, Kroon L. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies. Contraception. 2019 04; 99(4):239-243. |
Wilson L, Lin T, Wang L, Patel T, Tran D, Kim S, Dacey K, Yuen C, Kroon L, Brodowy B, Rodondi K. Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center. J Manag Care Spec Pharm. 2017 Feb; 23(2):163-169. |
Kroon LA, Corelli RL, Roth AP, Hudmon KS. Public perceptions of the ban on tobacco sales in San Francisco pharmacies. Tob Control. 2013 Nov; 22(6):369-71. |
Nam S, Janson SL, Stotts NA, Chesla C, Kroon L. Effect of culturally tailored diabetes education in ethnic minorities with type 2 diabetes: a meta-analysis. J Cardiovasc Nurs. 2012 Nov-Dec; 27(6):505-18. |
Wamsley M, Staves J, Kroon L, Topp K, Hossaini M, Newlin B, Lindsay C, O'Brien B. The impact of an interprofessional standardized patient exercise on attitudes toward working in interprofessional teams. J Interprof Care. 2012 Jan; 26(1):28-35. |
Kroon L. An analysis of dosage volume for halfway doses in the Victoza Pen. J Diabetes Sci Technol. 2011 Nov 01; 5(6):1625-6. |
Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011 Jul; 93(1):1-9. |
Jennifer Staves, Mehran Hossaini, Lisa Kroon, Caroline Lindsay, Barbara Newlin, Bridget O'Brien, Kimberly Topp, Maria Wamsley. Interprofessional Standardized Patient Exercise (ISPE): The Case of “Paul Harris”. MedEdPORTAL. 2011 Jan 1. |
Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Diabetes Care. 2010 Aug; 33(8):1747-9. |
Potter MB, Gildengorin G, Wang Y, Wu M, Kroon L. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign. J Am Pharm Assoc (2003). 2010 Mar-Apr 1; 50(2):181-7. |
Kroon L. An analysis of patient acceptance and safety of a prefilled insulin injection device. J Diabetes Sci Technol. 2009 Nov 01; 3(6):1439-41. |
Janson SL, Cooke M, McGrath KW, Kroon LA, Robinson S, Baron RB. Improving chronic care of type 2 diabetes using teams of interprofessional learners. Acad Med. 2009 Nov; 84(11):1540-8. |
Kroon L. Overview of insulin delivery pen devices. J Am Pharm Assoc (2003). 2009 Sep-Oct; 49(5):e118-31. |
Corelli RL, Fenlon CM, Kroon LA, Prokhorov AV, Hudmon KS. Evaluation of a train-the-trainer program for tobacco cessation. Am J Pharm Educ. 2007 Dec 15; 71(6):109. |
Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm. 2007 Sep 15; 64(18):1917-21. |
Robin L. Corelli, Christine M. Fenlon, Lisa A. Kroon, Alexander V. Prokhorov, Karen Suchanek Hudmon. Evaluation of a Train-the-Trainer Program for Tobacco Cessation. American Journal of Pharmaceutical Education. 2007 Jan 1; 71(6):109. |
Kroon LA. Drug interactions and smoking: raising awareness for acute and critical care providers. Crit Care Nurs Clin North Am. 2006 Mar; 18(1):53-62, xii. |
Irons BK, Kroon LA. Lipid management with statins in type 2 diabetes mellitus. Ann Pharmacother. 2005 Oct; 39(10):1714-9. |
Corelli RL, Kroon LA, Chung EP, Sakamoto LM, Gundersen B, Fenlon CM, Hudmon KS. Statewide evaluation of a tobacco cessation curriculum for pharmacy students. Prev Med. 2005 Jun; 40(6):888-95. |
Hudmon KS, Bardel K, Kroon LA, Fenlon CM, Corelli RL. Tobacco education in U.S. schools of pharmacy. Nicotine Tob Res. 2005 Apr; 7(2):225-32. |
Hudmon KS, Kroon LA, Corelli RL, Saunders KC, Spitz MR, Bates TR, Liang D. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81. |
Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy. J Am Pharm Assoc (2003). 2003 Sep-Oct; 43(5):573-82. |
Hudmon KS, Corelli RL, Chung E, Gundersen B, Kroon LA, Sakamoto LM, Hemberger KK, Fenlon C, Prokhorov AV. Development and implementation of a tobacco cessation training program for students in the health professions. J Cancer Educ. 2003; 18(3):142-9. |
Assemi M, Torres NM, Tsourounis C, Kroon LA, McCart GM. Assessment of an online consumer "Ask Your Pharmacist" service. Ann Pharmacother. 2002 May; 36(5):787-92. |
Karen Suchanek Hudmon, Robin L. Corelli, Lisa A. Kroon, Marilyn Standifer Shreve, Alexander V. Prokhorov. Reducing Pulmonary Disease: The Pharmacist’s Role in Smoking Cessation. Journal of Pharmacy Practice. 2001 Apr 1; 14(2):143-159. |